Jump to Content
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search
Table of Contents
Front Matter
Preliminary Material
Basic Concepts and Special Populations
RATIONAL USE OF DRUG CONCENTRATION MEASUREMENTS
ASSESSMENT OF KIDNEY FUNCTION
RENAL DRUG DOSING CONCEPTS
MEDICATION DOSING IN OVERWEIGHT AND OBESE PATIENTS
PHARMACOGENOMIC IMPACTS ON PHARMACOKINETICS
DRUG DOSING IN PEDIATRIC PATIENTS
CONSIDERATIONS FOR MEDICATION USE IN THE GERIATRIC PATIENT
Specific Drugs and Drug Classes
AMINOGLYCOSIDES
ANTIDEPRESSANTS
ANTIEPILEPTICS
ANTIREJECTION AGENTS
CARBAMAZEPINE
DIGOXIN
ETHOSUXIMIDE
UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARINS, AND FONDAPARINUX
LIDOCAINE
LITHIUM
PHENOBARBITAL
PHENYTOIN AND FOSPHENYTOIN
THEOPHYLLINE
VALPROATE
VANCOMYCIN
WARFARIN
APPENDICES
APPENDIX A
APPENDIX B
Back Matter
Index
PHARMACOGENOMIC IMPACTS ON PHARMACOKINETICS
in
Clinical Pharmacokinetics
Author:
Cheryl D. Cropp
DOI:
https://doi.org/10.37573/9781585286607.005
Restricted access
PDF Preview
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://publications.ashp.org/abstract/book/9781585286607/chapter05.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
[35.173.48.18]
35.173.48.18
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
